PACLITAXEL IN DOXORUBICIN-RESISTANT METASTATIC BREAST-CANCER PATIENTS

被引:8
作者
ANAND, A [1 ]
ANAND, A [1 ]
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
关键词
D O I
10.1093/jnci/87.21.1642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1642 / 1642
页数:1
相关论文
共 5 条
[1]  
GINNI L, 1995, J NATL CANCER I, V87, P1169
[2]  
OSHAUGHNESSY JA, 1994, SEMIN ONCOL, V21, P19
[3]  
RAVDIN PM, 1995, SEMIN ONCOL, V22, P17
[4]   PACLITAXEL AS 2ND AND SUBSEQUENT THERAPY FOR METASTATIC BREAST-CANCER - ACTIVITY INDEPENDENT OF PRIOR ANTHRACYCLINE RESPONSE [J].
SEIDMAN, AD ;
REICHMAN, BS ;
CROWN, JPA ;
YAO, TJ ;
CURRIE, V ;
HAKES, TB ;
HUDIS, CA ;
GILEWSKI, TA ;
BASELGA, J ;
FORSYTHE, P ;
LEPORE, J ;
MARKS, L ;
FAIN, K ;
SOUHRADA, M ;
ONETTO, N ;
ARBUCK, S ;
NORTON, L .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1152-1159
[5]  
SLEDGE GW, 1994, SEMIN ONCOL, V21, P15